As this happened, H.C. Wainwright reiterated its Sangamo Therapeutics Inc [SGMO] rating to a Buy in a research note published on December 10, 2024; the price target was $10. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who decreased its forecast for the stock in early November from “an Outperform” to “a Sector perform”. BofA Securities also remained covering SGMO and has decreased its forecast on April 28, 2023 with a “an Underperform” recommendation from previously “Neutral” rating. Wedbush revised its rating on February 27, 2023. It rated SGMO as “an Outperform” which previously was an “a Neutral”.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance Review of SGMO
On Tuesday, Sangamo Therapeutics Inc [NASDAQ:SGMO] saw its stock fall -2.50% to $1.95. Over the last five days, the stock has lost -9.30%. Sangamo Therapeutics Inc shares have risen nearly 258.92% since the year began. Nevertheless, the stocks have risen 302.06% over the past one year. While a 52-week high of $3.18 was reached on 11/08/24, a 52-week low of $0.30 was recorded on 07/05/24. SMA at 50 days reached $1.70, while 200 days put it at $0.93.
Levels Of Support And Resistance For SGMO Stock
The 24-hour chart illustrates a support level at 1.87, which if violated will result in even more drops to 1.78. On the upside, there is a resistance level at 2.04. A further resistance level may holdings at 2.12. The Relative Strength Index (RSI) on the 14-day chart is 48.39, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.07, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 72.88%. Stochastics %K at 33.33% indicates the stock is a holding.
How much short interest is there in Sangamo Therapeutics Inc?
A steep rise in short interest was recorded in Sangamo Therapeutics Inc stocks on 2024-11-29, dropping by -4.03 million shares to a total of 14.95 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 18.98 million shares. There was a decline of -26.95%, which implies that there is a negative sentiment for the stock.
